Haemonetics' VASCADE MVP® XL System Gains FDA Approval for Expanded Use Haemonetics Corporation receives FDA approval to expand the VASCADE MVP® XL system's use for advanced vascular closure procedures, enhancing patient care.

Haemonetics' VASCADE MVP® XL System Gains FDA Approval for Expanded Use #USA #FDA_Approval #Boston #Haemonetics #VASCADE_MVP